MEDTOX Diagnostics, Inc.

MEDTOX Diagnostics, Inc. is a point-of-care diagnostic company specializing in rapid immunoassay-based drug screening devices. The company manufactures rapid test cassettes, screening cups, and automated readers for substance abuse testing across clinical, workplace, criminal justice, and hospital settings. Primary product lines include MEDTOX PROFILE® cassettes and MEDTOX EZ-SCREEN® cups for screening up to 11 drugs of abuse with results in minutes, and the MEDTOX Scan® automated reader system for high-throughput, convenient screening. The company also offers a fentanyl test device recently cleared by FDA. MEDTOX serves hospitals, workplace wellness programs, clinical trial sponsors, and criminal justice agencies. As of 2026, the company is transitioning its trade name to Labcorp Point of Care under parent company Labcorp ownership. Products are designed for rapid point-of-care screening and typically achieve results within minutes of sample collection. The company provides training and customer support resources for clinical and administrative users.